Read More Analyst Ratings News Price Target Piper Sandler Maintains Neutral on Coupa Software, Raises Price Target to $67 By Benzinga Newsdesk September 7, 4:32 AM Piper Sandler analyst Brent Bracelin maintains Coupa Software (NASDAQ:COUP) with a Neutral and raises the price target from $65 to $67. COUP
Read More Dividends Earnings News Here’s How Much You Would Have Made Owning Cleveland-Cliffs Stock In The Last 5 Years By Benzinga Insights March 1, 11:03 AM Cleveland-Cliffs (NYSE:CLF) has outperformed the market over the past 5 years by 14.51% on an annualized basis producing… CLF
Read More Analyst Ratings Downgrades News Canaccord Genuity Downgrades Maxar Technologies to Hold By Benzinga Newsdesk December 16, 3:22 PM Canaccord Genuity analyst Austin Moeller downgrades Maxar Technologies (NYSE:MAXR) from Buy to Hold. MAXR
Read More Cannabis Markets News Psychedelics U.K.’s Prof. David Nutt Ranked World’s Top Psychopharmacologist: More On His Contributions & Advocacy By Lara Goldstein October 15, 8:06 PM Professor David Nutt, a cognitive sciences, addiction, cannabis and psychedelics researcher, has been ranked the #1 psychopharmacologist by ScholarGPS, a California-based American company owned and operated by Meta Analytics LLC. AWKNF